February 28, 2017 / 1:06 PM / a year ago

BUZZ-U.S. STOCKS ON THE MOVE-Target, Workday, Endo, Valeant, Perrigo

* Eikon search string for individual stock moves: STXBZ

* The Day Ahead newsletter: tmsnrt.rs/2ggOmBi

* The Morning News Call newsletter: tmsnrt.rs/2fwPLTh U.S. stock index futures were flat on Tuesday but hovered near all-time highs as investors awaited President Donald Trump's speech for details on his agenda for the economy.

Dow Jones Industrial Average futures were down 0.03 percent at 20,807, S&P 500 futures were down 0.08 percent at 2,366.25 and Nasdaq 100 futures were down 0.01 percent at 5,346.75.

** TARGET CORP, Monday close $66.91, -13.45 pct premarket

The U.S. retailer forecast a surprise drop in full-year sales at established stores and reported a steeper-than-expected fall in holiday-quarter sales due to “unexpected softness” at its stores.

** WORKDAY INC, Monday close $90.19, -5.26 pct premarket

The human resources software seller beat estimates on top and bottom line in the fourth quarter, but analysts said full-year guidance conservative.

“Workday is not showing enough incremental traction outside of its core business to warrant an additional premium to the stock’s current valuation,” Wunderlich Securities analyst said.

** TENET HEALTHCARE CORP, Monday close $22.67, -11.34 pct premarket

The hospital operator’s quarterly revenue fell for the first time in six years and also missed estimates and the company forecast lower-than-expected full-year earnings.

** SEADRILL PARTNERS LLC, Monday close $2.04, -11.76 pct premarket

The offshore rig contractor said it may file for Chapter 11 bankruptcy if no agreement is reached with its lenders.

** PERRIGO CO PLC, Monday close $84.68, -11.41 pct premarket

The drugmaker said it agreed to sell the royalty stream from its multiple sclerosis drug Tysabri to privately held Royalty Pharma for up to $2.85 billion. Perrigo also said it would delay the filing of its annual report until March, and would review past accounting practices, specifically its historical revenue recognition of its Tysabri sales.

** VALEANT PHARMACEUTICALS INTERNATIONAL INC, Monday close $16.71, -4.91 pct premarket

The Canadian drugmaker reported a 12.9 percent fall in quarterly revenue, its third straight quarter of a double-digit percentage decrease, as sales declined across its businesses and realized prices fell.

** SILVER BAY REALTY TRUST CORP, Monday close $18.17, +17.72 pct premarket

The REIT said it would be bought by Tricon Capital Group Inc for $1.4 billion in an all-cash deal.

** FRONTLINE LTD, Monday close $6.73, +4.75 pct premarket

** DHT HOLDINGS INC, Monday close $4.67, +0.64 pct premarket

Frontline said a higher and final offer for rival tanker firm DHT Holdings was rejected.

Frontline also reported net profit of $18.3 million in the fourth quarter, below consensus estimate of $20 million.

** ENDO INTERNATIONAL PLC, Monday close $13.29, +0.90 pct premarket

The drugmaker reported a 15.6 percent rise in quarterly revenue, largely driven by demand for its newly launched generic drugs, quetiapine and ezetimibe.

** PRICELINE GROUP INC, Monday close $1,632.01, +3.80 pct premarket

The travel website operator reported a 17.4 percent rise in fourth-quarter revenue, driven by higher hotel bookings.

Compiled by Aishwarya Venugopal in Bengaluru; Editing by Sriraj Kalluvila

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below